PP MPS Austria | Innovation News Network Science, Research & Innovation News Mon, 04 May 2020 10:10:41 +0000 en-GB hourly 1 https://wordpress.org/?v=6.5.5 Mucopolysaccharidoses: future therapies and perspectives /mucopolysaccharidoses-future-therapies/1107/?utm_source=rss&utm_medium=rss&utm_campaign=mucopolysaccharidoses-future-therapies Thu, 28 Nov 2019 00:00:00 +0000 /mucopolysaccharidoses-future-therapies/1107/ Susanne Gerit Kircher from the Medical University of Vienna and the Austrian MPS Society discusses how Mucopolysaccharidoses diseases are actually curable. Mucopolysaccharidoses (MPS) are a group of very rare disorders, also known as orphan diseases. They belong to the group of lysosomal storage diseases which are caused by a deficiency of one of the enzymes […]

The post Mucopolysaccharidoses: future therapies and perspectives appeared first on Innovation News Network.

]]> Rare diseases in Austria: exploring Mucopolysaccharide storage disorders /rare-diseases-in-austria-exploring-mucopolysaccharide-storage-disorders/751/?utm_source=rss&utm_medium=rss&utm_campaign=rare-diseases-in-austria-exploring-mucopolysaccharide-storage-disorders /rare-diseases-in-austria-exploring-mucopolysaccharide-storage-disorders/751/#respond Wed, 30 Oct 2019 00:00:00 +0000 /rare-diseases-in-austria-exploring-mucopolysaccharide-storage-disorders/751/ Professor Susanne Gerit Kircher of the Medical University of Vienna discusses the situation of rare diseases in Austria, including Mucopolysaccharide storage disorders. In Europe, a rare disease is defined as a condition which affects fewer than one in 2,000 people (or five in 10,000). The EU, with a population of 513.5 million people in 2019, […]

The post Rare diseases in Austria: exploring Mucopolysaccharide storage disorders appeared first on Innovation News Network.

]]> /rare-diseases-in-austria-exploring-mucopolysaccharide-storage-disorders/751/feed/ 0 Everything you need to know about the annual MPS therapy week /everything-know-annual-mps-therapy-week/1332/?utm_source=rss&utm_medium=rss&utm_campaign=everything-know-annual-mps-therapy-week /everything-know-annual-mps-therapy-week/1332/#respond Tue, 03 Sep 2019 23:00:00 +0000 /everything-know-annual-mps-therapy-week/1332/ From 11 July to 20 July 2019, the annual MPS therapy week and bi-annual MPS Conference was hosted in Hinterglemm, in the South-East of Salzburg, Austria. Over the course of those days, individuals affected with mucopolysaccharidoses and similar lysosomal disorders, such as mucolipidoses or alpha-mannosidoses, which all are severe chronic diseases with fatal outcome, gathered […]

The post Everything you need to know about the annual MPS therapy week appeared first on Innovation News Network.

]]> /everything-know-annual-mps-therapy-week/1332/feed/ 0 Mucopolysaccharidoses – one disease with many faces /mucopolysaccharidoses-disease/404/?utm_source=rss&utm_medium=rss&utm_campaign=mucopolysaccharidoses-disease /mucopolysaccharidoses-disease/404/#respond Wed, 20 Jun 2018 23:00:00 +0000 /mucopolysaccharidoses-disease/404/ Susanne Kircher, of the Medical University of Vienna, introduces the Austrian MPS Society and outlines the many challenges posed by mucopolysaccharidoses. Mucopolysaccharidoses (MPS) belong to the group of lysosomal diseases. They are characterised by enzyme deficiencies of lysosomal enzymes responsible for the degradation of mucopolysaccharides (glycosaminoglycans). These genetic diseases are very rare and are included […]

The post Mucopolysaccharidoses – one disease with many faces appeared first on Innovation News Network.

]]> /mucopolysaccharidoses-disease/404/feed/ 0